In addition to the improvement in renal inflammation upon hidrosmin treatment, we also detected a decreased activity of NF-κB and JAK/STAT, two signaling pathways that control key cellular responses during the onset and progression of DN [7,49]. This evidence concerns the gene NFKB1 and liver dysplastic nodule.